Lawrence Ogbechie
Psychiatry · Long Beach, CANPI 1003868217
Payments from drug & device makers
Across 390 payments — averaging $22.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$2K
- Sunovion Pharmaceuticals Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$913
- Otsuka America Pharmaceutical, Inc.$801
- AbbVie$639
- plus $2K from 11 others
What the payments were for
- Food & beverage$8,53899%
- Education$841%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 84 | $1,825 |
| Sunovion Pharmaceuticals Inc. | 67 | $1,120 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 49 | $1,042 |
| Alkermes, Inc. | 35 | $913 |
| Otsuka America Pharmaceutical, Inc. | 24 | $801 |
| AbbVie | 27 | $639 |
| Teva Pharmaceuticals USA, Inc. | 25 | $620 |
| Neurocrine Biosciences, Inc. | 18 | $446 |
| Lundbeck LLC | 22 | $363 |
| Johnson & Johnson | 9 | $251 |
| Almatica Pharma LLC | 12 | $184 |
| Idorsia Pharmaceuticals US Inc | 4 | $170 |
| E.r. Squibb & Sons, L.L.C. | 6 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $50 |
| Hologic Sales And Service, LLC | 2 | $46 |
| Merck | 1 | $20 |
| Neuronetics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,622 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 27 | $41,545 |
| FanaptIloperidone | 33 | $30,730 |
| TrintellixVortioxetine Hydrobromide | 34 | $15,542 |
| Lurasidone Hcl | 200 | $12,423 |
| Trazodone Hcl | 2,452 | $8,546 |
| Aripiprazole | 325 | $4,034 |
| Sertraline Hcl | 1,006 | $3,126 |
| Mirtazapine | 447 | $2,565 |
| Quetiapine Fumarate | 270 | $1,961 |
| Duloxetine Hcl | 345 | $1,904 |
| Asenapine Maleate | 18 | $1,894 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 136 | $1,876 |
| Zolpidem Tartrate | 402 | $1,434 |
| Memantine Hcl | 219 | $1,213 |
| Alprazolam | 166 | $1,177 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,042 | $41,54527 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $1,825 | $30,73033 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $50 | $15,54234 claims |
| Almatica Pharma LLCSertraline Hcl | $184 | $3,1261,006 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Long Beach
- Haig GoenjianLong Beach$6.3M
- Armen GoenjianLong Beach$5.3M
- Christopher ReistLong Beach$2.9M
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.